Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
FDA-2026-N-0005-0001RFI
Comments
4
Last activity Jul 13, 2026
Deadline
Closed on Jul 14, 2026
Closed Jul 14, 2026
Net supportiSupport minus oppose · campaigns included
+100%
+100% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
- Posted
- May 13, 2026
- Comment period
- May 13, 2026 – Jul 14, 2026
- FR Doc
- 2026-09533
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 1 of 4 comments
25%· analysis in progress
Stance breakdown
+100%
Net support
Support1Not yet analyzed3
Aggregates include form-letter campaigns. Excluding them, net support is +100% across organic comments.
Who commented
Breakdown by commenter type.
Academic
1
Not yet analyzed
3
Comments over time
Weekly arrivals, stacked by stance.
Posted May 13, 2026Deadline Jul 14, 2026
May 18Jul 13
Support1Oppose0Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Academic
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- Jul 13, 2026Comment from Critical Path InstituteAnalysis pending📎 AttachmentRead comment →
- Jul 13, 2026Comment from Pfizer IncAnalysis pending📎 AttachmentRead comment →
- Jul 13, 2026Comment from College of American PathologistsAnalysis pending📎 AttachmentRead comment →
- May 19, 2026Comment from David AskenaziSupportAcademic📎 Attachment
An academic clinical scientist and researcher in pediatric nephrology supports the initiative to develop urinary kidney safety biomarkers. The commenter emphasizes the importance of including infants in the research, highlights the impact of prematurity on biomarker values, and advocates for standardized, non-invasive urine collection methods.
Read comment →
